Stock Information
Corcept Therapeutics Inc (CORT)
Ticker Symbol: CORT
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $4,469.45 mil
Piotroski score: 6
PE Ratio: 44.737
EPS (TTM): 0.8303
Revenue (TTM): $6.34 M
Dividend Yield: N/A%
ROE: 15.34%
Latest News
-
Corcept Therapeutics Presents Final Overall Survival Data From Its Pivotal Phase 3 ROSELLA Trial Of Lifyorli Combined With The Chemotherapeutic Agent Nab-Paclitaxel In Patients With Platinum-Resistant Ovarian Cancer In A Late-Breaking Oral Presentation At The Society Of Gynecologic Oncology 2026 Annual Meeting On Women's Cancer; Data Demonstrate A 35 Percent Reduction In Risk Of Death
Fri, Apr 10, 2026 4:53 PM
-
Corcept Therapeutics Inc (NASDAQ:CORT): An Affordable Growth Stock Built on a Strong Foundation
Wed, Apr 8, 2026 12:51 PM
Key Financials
Financial data not available
